Quality of Life Outcomes for Cabozantinib Versus Everolimus in Patients With Metastatic Renal Cell Carcinoma: METEOR Phase III Randomized Trial.
暂无分享，去创建一个
R. Motzer | T. Powles | T. Choueiri | D. Cella | P. Mainwaring | B. Escudier | S. Pal | B. Roth | D. Heng | F. Donskov | N. Tannir | H. Hammers | Thomas E. Hutson | C. Scheffold | M. Schmidinger | M. Mangeshkar | F. Marteau | J. Lee | K. Peltola | J. Baer | P. Williams